Gubra AS (CHIX:GUBRAC) Net Margin % : -25.57% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Gubra AS's Net Income for the six months ended in Dec. 2023 was kr-26.4 Mil. Gubra AS's Revenue for the six months ended in Dec. 2023 was kr103.2 Mil. Therefore, Gubra AS's net margin for the quarter that ended in Dec. 2023 was -25.57%.

The historical rank and industry rank for Gubra AS's Net Margin % or its related term are showing as below:

CHIX:GUBRAc' s Net Margin % Range Over the Past 10 Years
Min: -21.72 Med: 4.77 Max: 26.61
Current: -21.72

CHIX:GUBRAc's Net Margin % is ranked better than
67.16% of 1020 companies
in the Biotechnology industry
Industry Median: -150.095 vs CHIX:GUBRAc: -21.72

Gubra AS Net Margin % Historical Data

The historical data trend for Gubra AS's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Net Margin % Chart

Gubra AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

7.37

26.61

2.16

-21.72

Gubra AS Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial			-	-7.02	10.98	-17.82	-25.57

Competitive Comparison of Gubra AS's Net Margin %

For the Biotechnology subindustry, Gubra AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gubra AS's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Net Margin % distribution charts can be found below:

* The bar in red indicates where Gubra AS's Net Margin % falls into.

Gubra AS Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Gubra AS's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-44.524	/	205.005
	=	-21.72 %

Gubra AS's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-26.385	/	103.188
	=	-25.57 %

Gubra AS (CHIX:GUBRAc) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Gubra AS Net Margin % Related Terms

Thank you for viewing the detailed overview of Gubra AS's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gubra AS (CHIX:GUBRAC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

GUBRA:Denmark PI3:Germany

Address

Hørsholm Kongevej 11B, Hørsholm, DNK, 2970

Website

https://www.gubra.dk

Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (CHIX:GUBRAC) Headlines

No Headlines